Worldwide revenue of $378.7 million, an increase of 18.4% from third quarter 2023GAAP fully diluted earnings per share of $1.79, compared to ...

She's spending a fraction of what elite biohackers do for longevity, and getting great results.

After leaving her job, Chiren got help. She was put on hormone replacement therapy, which instantly alleviated the symptoms ...

Here's a look at some of the most consequential changes in health policies that could hinge on who wins the White House.

Results from Phase 3 ENERGIZE-T Study of Mitapivat in Transfusion-dependent Thalassemia will be Presented in Oral Session –– Tebapivat Phase 1 ...